Monitoring early dynamic changes of plasma cell-free DNA and pretreatment pre-albumin to predict chemotherapy effectiveness and survival outcomes in advanced non-small cell lung cancer

BACKGROUND: This study aimed to determine whether plasma cell-free DNA (cfDNA) and pretreatment parameters provide useful therapeutic response and prognostic information for advanced non-small cell lung cancer (NSCLC) patients. METHODS: A total of 114 patients with advanced NSCLC who underwent syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jia, Shao, Jingjing, Zhang, Xunlei, Wei, Sheng, Cai, Hongyu, Wang, Gaoren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987881/
https://www.ncbi.nlm.nih.gov/pubmed/35402598
http://dx.doi.org/10.21037/atm-22-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987881/
https://www.ncbi.nlm.nih.gov/pubmed/35402598
http://dx.doi.org/10.21037/atm-22-12

Ejemplares similares